Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Operating Grant - PA: Drug Safety and Effectiveness (bridge funding)

McMaster University

$100,000.00

The impact of genetic variants on response to methadone in opioid addiction.

FY 2012-13

Summary
There is growing concern regarding rising rates of addiction to prescription opioid medications like codeine and morphine among Canadians. There are numerous factors contributing to this crucial health problem, including the increased availability of opioids, along with social and psychological factors. Genes may also play an important part in the development of addictive behavior and response to treatment of addiction disorders. Critically, however, we have limited information concerning how genes support the start and continuation of addictive behaviors because studies that were done previously have used small number of patients and inconsistent methods. The most commonly used drug in the treatment of opioid addictions is called methadone, also an opioid, has significant side effects including doubling the risk of death in patients when starting treatment. In addition, it is difficult to decide on a safe maintenance dose because our bodies use or metabolize a given dose of methadone at different rates depending on the individual's genetic make-up. This study will help establish safe and effective methadone dosing procedures based on the individual patient's genetic make-up. Here, we will sequence the genes involved in the development of addictive behavior and methadone metabolism in order to see how they affect the patients' response to methadone. This approach will help us to identify patients who are fast or slow metabolizers of the drug. Moreover, using this personalized approach to medicine, we will be able to safely adjust the dose of methadone to help achieve a good response, thereby reducing the dangerous side effects of the drug.
Program
Operating Grant - PA: Drug Safety and Effectiveness (bridge funding)
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
274146
Name
Samaan Zainab
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
Behavioural Sciences - B: Clinical Behavioural Sciences
Projecttitle
The impact of genetic variants on response to methadone in opioid addiction.
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant - PA: Drug Safety and Effectiveness (bridge funding)
Keyworddelim
Addiction; Drugs; Effectiveness; Genes; Metabolism; Methadone; Opiods; Response; Treatment; Urine
Abstract
There is growing concern regarding rising rates of addiction to prescription opioid medications like codeine and morphine among Canadians. There are numerous factors contributing to this crucial health problem, including the increased availability of opioids, along with social and psychological factors. Genes may also play an important part in the development of addictive behavior and response to treatment of addiction disorders. Critically, however, we have limited information concerning how genes support the start and continuation of addictive behaviors because studies that were done previously have used small number of patients and inconsistent methods. The most commonly used drug in the treatment of opioid addictions is called methadone, also an opioid, has significant side effects including doubling the risk of death in patients when starting treatment. In addition, it is difficult to decide on a safe maintenance dose because our bodies use or metabolize a given dose of methadone at different rates depending on the individual's genetic make-up. This study will help establish safe and effective methadone dosing procedures based on the individual patient's genetic make-up. Here, we will sequence the genes involved in the development of addictive behavior and methadone metabolism in order to see how they affect the patients' response to methadone. This approach will help us to identify patients who are fast or slow metabolizers of the drug. Moreover, using this personalized approach to medicine, we will be able to safely adjust the dose of methadone to help achieve a good response, thereby reducing the dangerous side effects of the drug.
Competitiondate
201209
Approvedterm2
1 yr 0 mth
Pinamesdelim
Samaan, Zainab; Paré, Guillaume
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~